REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies

Movement Disorders : Official Journal of the Movement Disorder Society
Erik K St LouisBradley F Boeve

Abstract

Rapid eye movement sleep behavior disorder is characterized by dream enactment and complex motor behaviors during rapid eye movement sleep and rapid eye movement sleep atonia loss (rapid eye movement sleep without atonia) during polysomnography. Rapid eye movement sleep behavior disorder may be idiopathic or symptomatic and in both settings is highly associated with synucleinopathy neurodegeneration, especially Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. Rapid eye movement sleep behavior disorder frequently manifests years to decades prior to overt motor, cognitive, or autonomic impairments as the presenting manifestation of synucleinopathy, along with other subtler prodromal "soft" signs of hyposmia, constipation, and orthostatic hypotension. Between 35% and 91.9% of patients initially diagnosed with idiopathic rapid eye movement sleep behavior disorder at a sleep center later develop a defined neurodegenerative disease. Less is known about the long-term prognosis of community-dwelling younger patients, especially women, and rapid eye movement sleep behavior disorder associated with antidepressant medications. Patients with rapid eye movement sleep behavior disorder are ...Continue Reading

References

Sep 1, 1989·The American Journal of Psychiatry·C H SchenckM W Mahowald
Apr 1, 1967·Physiological Reviews·M Jouvet
Mar 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·K K GnanalinghamP Bannister
May 23, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·G PlazziE Lugaresi
Aug 2, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·B F BoeveJ E Parisi
Oct 31, 2002·Journal of the International Neuropsychological Society : JINS·Tanis J FermanRobert J Ivnik
Jun 5, 2003·Annals of Neurology·Maria Livia FantiniJacques Montplaisir
Aug 18, 2004·Journal of Geriatric Psychiatry and Neurology·Bradley F BoeveTanis J Ferman
Sep 1, 2004·Cell and Tissue Research·Heiko BraakKelly Del Tredici
Dec 29, 2004·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Keith A JosephsSteven Vernino
Apr 28, 2005·Sleep Medicine·S NightingaleA J Williams
Aug 11, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Felix GeserIan McKeith
Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
Mar 1, 2006·Neurology·Anja WeyerThomas Klockgether
Apr 26, 2006·Neurology·Maja Tippmann-PeikertB Mark Keegan
May 12, 2006·Nature·Jun LuClifford B Saper
Sep 19, 2006·The Clinical Neuropsychologist·Tanis J FermanDennis W Dickson
Oct 10, 2006·Brain Research Bulletin·Maria Livia FantiniLuigi Ferini-Strambi
Oct 31, 2006·Sleep·Jean-François GagnonJacques Montplaisir
Apr 7, 2007·Brain : a Journal of Neurology·B F BoeveH Braak
Aug 9, 2007·Sleep·Yves DauvilliersJacques Montplaisir
Aug 19, 2007·Sleep·Valérie Cochen De CockIsabelle Arnulf
Sep 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Karin Stiasny-KolsterWolfgang H Oertel
Jan 25, 2008·Neurology·J Massicotte-MarquezJ Montplaisir
Jun 4, 2008·Sleep·Birgit FrauscherUNKNOWN SINBAR (Sleep Innsbruck Barcelona group)

❮ Previous
Next ❯

Citations

Apr 25, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Alex Iranzo, Michael H Silber
Apr 18, 2018·Annals of Neurology·Daphné Génier MarchandJean-François Gagnon
Nov 22, 2017·Neurodegenerative Disease Management·Ruth B SchneiderIrene H Richard
Sep 6, 2017·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Giacomo ChiaroFederica Provini
Dec 13, 2018·Chinese Medical Journal·Chun-Feng LiuK Ray Chaudhuri
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Klaus SeppiUNKNOWN the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders So
Jul 20, 2019·Human Brain Mapping·Arianna SalaDaniela Perani
Aug 15, 2019·Acta Neurologica Scandinavica·Hava Özlem DedeDerya Karadeniz
Oct 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Leslie M ShawSheila Fifer
Sep 14, 2019·The International Journal of Neuroscience·Hiroshi Kataoka, Kazuma Sugie
Nov 30, 2019·Frontiers in Neurology·Dongming YangLifeng Yang
Mar 21, 2018·Neurology·Bart LuttersPeter J Koehler
May 31, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Andrea PilottoAristide Merola
Mar 21, 2020·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Stuart J McCarterWolfgang Singer
Jan 29, 2020·Aging Clinical and Experimental Research·Marina De RuiGiuseppe Sergi
Aug 9, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Matthew R Burns, Nikolaus R McFarland
Oct 11, 2017·Current Treatment Options in Neurology·Babak Tousi
May 23, 2019·Annals of the American Thoracic Society·Lucas M DonovanEric J Hawkins
Apr 8, 2020·Movement Disorders Clinical Practice·Douglas M WallaceRobert A Hauser
Feb 14, 2021·Journal of Parkinson's Disease·Amir Ashraf-GanjoueiZahra Vahabi
Feb 3, 2021·Healthcare·Seunghyeon LeeHyo-Bum Kwak
Mar 5, 2021·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Yu Jin Jung, Eungseok Oh
Jan 22, 2018·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Jesper JeppesenMichael Sommerauer
Mar 22, 2019·Neuron·Matthew M McGregor, Alexandra B Nelson
May 22, 2018·Parkinsonism & Related Disorders·David R ShprecherThomas G Beach
May 23, 2021·Aging Clinical and Experimental Research·Kangfu YinXinglong Yang
May 26, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Andrea QuattroneAldo Quattrone
Jun 4, 2021·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A V ZakharovE V Khivintseva
Jun 13, 2021·Parkinsonism & Related Disorders·Cristina RascunàAlessandra Nicoletti
Apr 30, 2020·Neuro-degenerative Diseases·Yu Jin JungBeomseok Jeon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.